GRAIL, Inc.
GRALDiagnostics & Research
$158.92+0.66%As of Oct 29vs prior close
- Market cap
- $7.1B
- P/E (TTM)
- –
- From 52W high
- 0.00%
- EPS (LTM)
- -$9.68
- Revenue (LTM)
- $165.3M
- Net margin
- -236.95%
- Dividend yield
- 0.00%
Nomior Score
31
Speculative ChargeSpeculativeBottom 17% of the scored universe
Growth67
Quality19
Value18
Momentum64
Resilience32
Growth
+38.37%revenue a year over 3 fiscal years
YE22 $55.6MLTM $165.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 389% of revenue, narrower by 58 pts on a year.
Who owns it
2funds